Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
NCT07095790
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
580
Enrollment
OTHER
Sponsor class
Conditions
Mild Stroke
Interventions
DRUG:
Tirofiban+Oral Dual Antiplatelet Therapy
DRUG:
Oral Dual Antiplatelet Therapy
Sponsor
Second Affiliated Hospital of Soochow University